Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0104545008
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 01964437 | SANDOZ CANADA INCORPORATED | MORPHINE SULFATE INJ 2MG/ML USP | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Marketed | 02500701 | JAMP PHARMA CORPORATION | MORPHINE SULFATE INJECTION | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Cancelled Pre Market | 02382989 | SANDOZ CANADA INCORPORATED | MORPHINE SULFATE INJECTION SDZ | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Cancelled Pre Market | 00850314 | PFIZER CANADA ULC | MORPHINE SULFATE INJECTION USP | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Marketed | 02242484 | SANDOZ CANADA INCORPORATED | MORPHINE SULFATE INJECTION USP | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Marketed | 02482681 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / 1 ML |
Approved | 02488620 | FRESENIUS KABI CANADA LTD | MORPHINE SULFATE INJECTION, USP | Human | Yes | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / 1 ML |
Cancelled Post Market | 02137240 | HOSPIRA HEALTHCARE ULC | MORPHINE SULPHATE INJECTION 2MG/ML | Human | No | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Cancelled Post Market | 02003759 | DAVID BULL LABORATORIES (CANADA) INC. | MORPHINE SULPHATE INJECTION BP 2MG/ML | Human | No | Narcotic (CDSA I) | 1 | MORPHINE SULFATE | 2 MG / ML |
Application information
Related information
Contact us
Version 4.0.3